000 04473nam a22004335i 4500
999 _c9780
_d9780
001 9780
003 DE-He213
005 20210518040411.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 170930s2018 gw | s |||| 0|eng d
020 _a9783319627106
024 7 _a10.1007/978-3-319-62710-6
_2doi
040 _aES-MaUEC
_bspa
_dES-VaUE
050 4 _aRC280.P7
_bA285 2018 EB
245 1 0 _aActive Surveillance for Localized Prostate Cancer:
_bA New Paradigm for Clinical Management
_cedited by Laurence Klotz
250 _a2nd edition
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Humana Press
_c2018
300 _a1 recurso en línea (XII, 250 páginas 39 ilustraciones, 27 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aCurrent Clinical Urology
_x2197-7194
490 0 _aMedicine (Springer-11650)
505 0 _aCancer Overdiagnosis and Overtreatment -- Can We Screen and Still Reduce Overdiagnosis? -- The Role of Fear in Overdiagnosis and Overtreatment -- Ethical and Legal Considerations in Active Surveillance for Prostate Cancer -- Gleason 6 Tumors Should Still Be Labeled As Cancer -- Risk Based Selection for Active Surveillance -- Surveillance at the Margins: Management of High Volume Gleason 6, PSA > 10, or Gleason 3+4 -- How Should Patients on Active Surveillance be Followed? -- Triggers for Intervention -- MR Imaging in Prostate Tumor Volume Assessment: How Accurate? -- Can MRI Replace Biopsy in Men on Surveillance? -- Tissue Based Markers for Risk Prediction -- International AS Registry: The Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative -- Better Informed Decision Making to Optimize Patient Selection -- How Does QOL Compare Between Surveillance and Active Treatment? -- The Potential Benefits of Diet and Physical Activity among Active Surveillance Patients with Low-Burden Prostate Cancer -- Is there a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of 5-ARIs, Statins, and Metformin -- The Update of Active Surveillance around the World: Utilization and Outcomes -- Tissue Preservation – Active Surveillance and Focal Therapy as Complimentary Strategies -- The Economics of Active Surveillance for Prostate Cancer -- Research Questions in Active Surveillance.
520 3 _aThis fully updated and revised new edition provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in prostate cancer. The book reviews new data about molecular characteristics of the disease, profiles the new grading system for prostate cancer introduced in 2015, and provides new perspectives about imaging of prostate cancer, as well as the role of targeted biopsies. The text summarizes the role of biomarkers and MRI in patient selection and management and details the world wide results of active surveillance. Specific chapters address communication and ethical issues, QOL outcomes, economic aspects, and psycho-social aspects of surveillance. The role of focal therapy for low risk disease is summarized, and the data supporting preventive interventions during surveillance reviewed. This text will serve as a very useful resource for physicians and researchers dealing with, and interested in this common malignancy, as it provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts.
650 7 _aPróstata
_xCáncer
_9182337
_2embne
650 7 _aUrología
_2embne
_9138565
650 7 _aOncología
_9139207
_2embne
700 1 _aKlotz, Laurence
_eeditor literario
_0http://id.loc.gov/authorities/names/nb2012021674
_0http://viaf.org/viaf/105439996
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319627090
776 0 8 _iEdición impresa:
_z9783319627113
776 0 8 _iEdición impresa:
_z9783319873756
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-62710-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _db